Status:
UNKNOWN
RF TKA Prehabilitation
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the effects of the radiofrequency applied to the sensory innervation of the knee, with respect to a control group (standard therapy), in a prehabilitation progr...
Detailed Description
Postoperative functional capacity following TKA surgery has been strongly associated with preoperative functional status. Presence of pain, poor strength and flexibility, and limited ability to comple...
Eligibility Criteria
Inclusion
- Chronic knee pain, with Dynamic VAS ≥ 5
- Scheduled for elective total knee arthroplasty
- Functional impairment due to pain because of knee osteoarthritis
- Taking medications to control the pain.
- Ability to perform the 6 MWT.
Exclusion
- ASA physical status \> 3
- Morbid obesity (BMI \>40)
- Revision of total knee arthroplasty
- Mayor neuropsychiatric disease
- Mayor cardiac, renal or hepatic failure
- Anemia (hematocrit \<30%)
- Immunosuppression
- Rheumatoid arthritis
- Allergy to opioids, to local anesthetics or other medications used in the study,
- Chronic regular use of large doses of opioids (\>20mg equivalent of morphine/day) or sedatives
- Unwillingness to have spinal anesthesia
- History of recent drug abuse
- Contraindication to receive regional anesthesia (e.g. coagulation defect)
- Inability to walk before the surgery
- Inability to perform physical tasks
- Contraindications to physical exercise and training
- Prior mayor knee surgery
- Connective tissue diseases affecting the knee
- Serious neurologic disorders
- Injection with steroids or hyaluronic acids during the previous 3 months
- Active sciatic pain
- Anticoagulant medications
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03758300
Start Date
December 1 2017
End Date
December 31 2018
Last Update
November 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal General Hospital
Montreal, Quebec, Canada, H3A 1A1